Paper41313745
Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.
Martin JD and 19 others. Adv Sci (Weinh), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer. Papers, record 41313745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41313745
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Immune Checkpoint Inhibitors | Major topic |
| Dexamethasone | Major topic |
| Breast Neoplasms | Major topic |
| Adrenal Cortex Hormones | Major topic |
| Animals | |
| Mice | |
| Female | |
| Disease Models, Animal | |
| Glucocorticoids | |
| Cell Line, Tumor |
Source PubMed
Grants13
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 18H05378 | Grants-in-Aid Challenging Research | PubMed | ||
| 23H00546 | Grants-in-Aid for Scientific Research A | PubMed | ||
| 22K19541 | Grants-in-Aid for Exploratory Research | PubMed | ||
| 21KK0197 | Promotion of Joint International Research | PubMed | ||
| Ministry of Education, Culture, Sports, Science and Technology | PubMed | |||
| European Regional Development Fund | PubMed | |||
| INFRASTRUCTURE/1216/0052 | Research Promotion Foundation | PubMed | ||
| POST-DOC/0718/0084 | Research Promotion Foundation | PubMed | ||
| P16731 | Japan Society for the Promotion of Science | PubMed | ||
| ERC-2013-StG-336839 | HORIZON EUROPE European Research Council | PubMed | ||
| ERC-2018-PoC-838414 | HORIZON EUROPE European Research Council | PubMed | ||
| ERC-2019-CoG-863955 | HORIZON EUROPE European Research Council | PubMed | ||
| JP17cm0106202 | Japan Agency for Medical Research and Development | PubMed |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29664018 | Increased vessel perfusion predicts the efficacy of immune checkpoint blockade. | J Clin Invest | 2018 | https://conductscience.org/library/papers/29664018 | PubMed |
| 2 | 25739764 | Immunological mechanisms of the antitumor effects of supplemental oxygenation. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25739764 | PubMed |
| 3 | 25924065 | Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. | Nature | 2015 | https://conductscience.org/library/papers/25924065 | PubMed |
| 4 | 29455927 | Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29455927 | PubMed |
| 5 | 32042344 | TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity. | Theranostics | 2020 | https://conductscience.org/library/papers/32042344 | PubMed |
| 6 | 33465258 | Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and Immunotherapy. | Oncologist | 2021 | https://conductscience.org/library/papers/33465258 | PubMed |
| 7 | 37778345 | Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. | Oncology | 2024 | https://conductscience.org/library/papers/37778345 | PubMed |
| 8 | 32658626 | Antiemetics: ASCO Guideline Update. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/32658626 | PubMed |
| 9 | 16224268 | Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells. | J Immunother | 2005 | https://conductscience.org/library/papers/16224268 | PubMed |
| 10 | 23897981 | Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. | J Exp Med | 2013 | https://conductscience.org/library/papers/23897981 | PubMed |
| 11 | 31187975 | Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment. | ACS Nano | 2019 | https://conductscience.org/library/papers/31187975 | PubMed |
| 12 | 15965952 | CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. | J Cell Physiol | 2006 | https://conductscience.org/library/papers/15965952 | PubMed |
| 13 | 30755690 | The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/30755690 | PubMed |
| 14 | 33239433 | Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33239433 | PubMed |
| 15 | 25477332 | Trafficking of T cells into tumors. | Cancer Res | 2014 | https://conductscience.org/library/papers/25477332 | PubMed |
| 16 | 29508855 | Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29508855 | PubMed |
| 17 | 34106045 | Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. | Elife | 2021 | https://conductscience.org/library/papers/34106045 | PubMed |
| 18 | 8402656 | Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. | Cancer Res | 1993 | https://conductscience.org/library/papers/8402656 | PubMed |
| 19 | 39886162 | Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer. | BMJ Oncol | 2024 | https://conductscience.org/library/papers/39886162 | PubMed |
| 20 | 23045683 | Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/23045683 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41313745
GET https://conductscience.org/api/papers/v1/41313745/references?page=2